Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary

Q: What sector and industry does Pliant Therapeutics (PLRX) operate in?

Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.

Open	$11.680
Close	-
Volume / Avg.	40.004K / 360.919K
Day Range	11.210 - 11.820
52 Wk Range	11.730 - 30.850
Market Cap	$717.793M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	12.64%
Days to Cover	20.96

Recent News

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

Avi Kapoor

Why Is Liver Disease-Focused Pliant Therapeutics Stock Trading Lower Today?

Pliant Therapeutics reports 12-week interim data for bexotegrast in INTEGRIS-PSC Phase 2a trial. 320 mg group met primary and secondary endpoints, showing well-tolerance and reduction in liver fibrosis.

Vandana Singh

Johnson Controls International To Rally Over 27%? Here Are 10 Other Analyst Forecasts For Wednesday

Keybanc cut the price target for Danaher Corporation (NYSE: DHR) from $325 to $300. Keybanc analyst Paul Knight maintained an Overweight rating. Danaher shares rose 0.6% to $248.75 in pre-market trading.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Pliant Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pliant Therapeutics (PLRX) stock?

You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Pliant Therapeutics's (PLRX) competitors?

Other companies in Pliant Therapeutics’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Verona Pharma (NASDAQ:VRNA).

What is the target price for Pliant Therapeutics (PLRX) stock?

The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 38.00 expecting PLRX to rise to within 12 months (a possible 235.69% upside). 29 analyst firms have reported ratings in the last year.

Current Stock Price for Pliant Therapeutics (PLRX)?

The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $11.32 last updated Today at April 25, 2024 at 9:54 AM EDT.

Does Pliant Therapeutics (PLRX) pay a dividend?

There are no upcoming dividends for Pliant Therapeutics.

When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?

Pliant Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Pliant Therapeutics (PLRX) going to split?

There is no upcoming split for Pliant Therapeutics.

What sector and industry does Pliant Therapeutics (PLRX) operate in?

Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-